Home Cart Sign in  
Chemical Structure| 1191252-49-9 Chemical Structure| 1191252-49-9

Structure of IOWH-032
CAS No.: 1191252-49-9

Chemical Structure| 1191252-49-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

IOWH-032 is a potent CFTR inhibitor (IC50=1.01 μM) in T84 and CHO-CFTR cell based assays.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of IOWH-032

CAS No. :1191252-49-9
Formula : C22H15Br2N3O4
M.W : 545.18
SMILES Code : O=C(C1=NC(C2=CC(Br)=C(O)C(Br)=C2)=NO1)NCC3=CC=C(OC4=CC=CC=C4)C=C3
MDL No. :MFCD25977119
InChI Key :DSFNLJXHXBIKDS-UHFFFAOYSA-N
Pubchem ID :135565181

Safety of IOWH-032

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • CFTR

    CFTR, IC50:1.01 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
Vero cells 5-20 µM 72 hours Inhibited HSV-1 and HSV-2-induced cytopathic effects Viruses. 2024 Aug 16;16(8):1308
MucilAir™ wt/wt-CFTR 10 µM 1 hour Inhibition of CFTR function, reducing SARS-CoV-2 viral replication Cells. 2022 Apr 15;11(8):1347
CFBE41o- WT cells 10 µM 1 hour Inhibition of CFTR function, significantly reducing SARS-CoV-2 viral replication Cells. 2022 Apr 15;11(8):1347
wt/wt-CFTR MucilAir™ cells 10 μM 0, 24, 48 hours Assessment of the effect of IOWH-032 on tissue integrity, showing no significant reduction in tissue integrity after 48 h of treatment at 10 μM. Cells. 2023 Feb 28;12(5):776
CFBE41o- WT cells 0.1, 1, 5, 7, 10, 20, 30, 50, 100 μM 1, 24, 48 hours Evaluation of cytotoxicity of IOWH-032, showing CC50 > 50 μM at 48 h post-treatment, with no significant cytotoxicity at the CFTR inhibitory concentration IC50 (8 μM). Cells. 2023 Feb 28;12(5):776
Human HaCaT keratinocytes cells 5-20 µM 24 hours Suppressed HSV-1 and HSV-2 replication, reduced viral glycoprotein D synthesis and viral gene expression Viruses. 2024 Aug 16;16(8):1308
human lung cancer cells 4 μM Evaluated cytotoxicity of IOWH-032, observed ~50% reduction in cell viability ACS Chem Biol. 2024 Jul 19;19(7):1593-1603
monkey kidney cells 4 μM Evaluated cytotoxicity of IOWH-032, observed ~50% reduction in cell viability ACS Chem Biol. 2024 Jul 19;19(7):1593-1603

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.83mL

0.37mL

0.18mL

9.17mL

1.83mL

0.92mL

18.34mL

3.67mL

1.83mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories